Somatic cell-embryo coculture enhances embryo development in vitro by producing embryotrophic factor(s) and/or removing harmful substances from the culture environment. Yet, the underlying molecular mechanisms on how somatic cells remove the toxicants from the culture medium remain largely unknown. By using suppression subtractive hybridization, we identified a number of mouse oviductal genes that were upregulated when developing preimplantation embryos were present in the oviduct. Epoxide hydrolase 1, microsomal (Ephx1 previously known as mEH) was one of these genes. EPHX1 detoxifies genotoxic compounds and participates in the removal of reactive oxygen species (ROS). The transcript of Ephx1 increases in the oviductal epithelium at the estrus stage and in Day 3 of pregnancy as well as in the uterus of ovariectomized mice injected with estrogen or progesterone. Human oviductal epithelial cells OE-E6/E7 express EPHX1 and improve mouse embryo development in vitro. Addition of an EPHX1 inhibitor, cyclohexene oxide (CHO) or 1,1,1-trichloropropene 2,3-oxide (TCPO), to the culture medium increased intracellular and extracellular ROS levels of OE-E6/E7 cells and suppressed the beneficial effect of the cells on embryo development; CHO and TCPO at these concentrations had no adverse effect on OE-E6/ E7 growth and embryo development in vitro. Taken together, EPHX1 in oviductal cells may enhance the development of cocultured embryos by protecting them from oxidative stress. Our result supports the notion that somatic cell coculture may enhance embryo development via removal of deleterious substances in the culture medium.
INTRODUCTION
In mammals, fertilization and early embryonic development begin in the oviduct [1] . In order to cope with the changing needs of the developing embryos, the maternal environment inside the reproductive tract are actively modified [2] [3] [4] .
Evidence is accumulating that the embryo interacts with the female reproductive tract before implantation [5] [6] [7] . Indeed, it is generally accepted that coculturing with somatic cells (e.g., oviductal epithelial cells) enhances embryo development in vitro [3] . Studies from our laboratory and others have demonstrated that oviductal epithelial cells produce growth factors, cytokines, and other embryotrophic factors of unknown identities to support embryo development in vitro (reviewed in [3] ). This coculture effect is not limited to cells from the reproductive tract. Yet, the underlying molecular mechanism of this coculture effect remains obscure. Apart from producing embryotrophic compounds, oviductal cells may also modify the culture environment for better embryo development by removing deleterious substances. It has been suggested that an imbalance between the production of toxic compounds, such as oxygen-based free radicals and lipid peroxidase, and the detoxification and scavenging of harmful molecules in vivo may affect preimplantation embryo development [8] .
Epoxide hydrolase (EH) is a class of enzymes important in detoxifying genotoxic compounds and catabolizing and regulating signaling molecules. In microorganisms, EHs seem to be important in the catabolism of specific derivatives of tartaric acid and limonene, and of environmental contaminants such as epichlorohydrin [9] . In plants, EHs seem to be important in cuticle formation, responses to stresses, and pathogen defenses. In mammals, there are several EHs, including cholesterol-epoxide hydrolase (ChEH, EC 3.3.2.11); epoxide hydrolase 1, microsomal (EPHX1); hepoxilin hydrolase; and epoxide hydrolase 2, cytoplasmic (EPHX2). ChEH mainly hydrates the 5,6-oxide of cholesterol and other D 5 -epoxy steroids [9] . EPHX1 and EPHX2 were first distinguished by their subcellular localizations. Later, they were also found to have distinct and complementary substrate specificity. Human EHs catalyze the hydration of epoxides to form the corresponding dihydrodiols [10] . This hydration process is essentially irreversible and produces mainly metabolites of lower reactivity that are readily excreted. EPHX1 possesses a strong hydrophobic transmembrane domain of approximately 20 residues anchoring the protein to cellular membranes [9, 10] . In the liver, EPHX1 resides in both the smooth endoplasmic reticulum and the plasma membrane. EPHX1 and EPHX2 share 39% amino acid homology at the C-terminal. Interestingly, recent findings suggest that EPHX2 is involved in the regulation of blood pressure and inflammation, and that EPHX1 is involved in xenobiotic metabolism and the onset of several diseases [9] .
Previously, we demonstrated that human oviductal epithelial cells affect the gene expression of developing embryos in vitro [11, 12] partly via complement component 3 derivatives [12, 13] . The developing embryos, in turn, altered the gene expression of the oviduct [5, 14, 15] . By comparing the gene expression profiles in the oocyte-containing oviduct with that of the embryo-containing oviduct, we had isolated more than a dozen genes differentially expressed in the embryo-containing oviduct [5, 14] . Yet, the functions of these genes on embryo development are largely unknown. In this study, we report the characterization of Ephx1 as one of the up-regulated genes found in the embryo-containing oviduct. The role of EPHX1 on embryo development is studied in vitro by coculturing preimplantation mouse embryos with human oviductal epithelial cells (OE-E6/E7) with or without an EPHX1 inhibitor, cyclohexene oxide or 1,1,1-trichloropropene-2,3-oxide. Our results strongly suggest that EPHX1 may help to maintain an optimal oviductal microenvironment conducive to embryo development in vitro.
MATERIALS AND METHODS

Subtraction Suppressive Hybridization and Tissue Collection
The identification of Ephx1 from the embryo-containing oviduct was performed as reported previously [5, 14] . The research protocol was approved by the Committee on the Use of Live Animals in Teaching and Research, the University of Hong Kong. Oviducts from cyclic (proestrus, estrus, metestrus, and diestrus) ICR (imprinting control region, CD-1) mice (purchased from Harlan UK Ltd., Bicester, Oxon, UK), pregnant mice, and pseudopregnant mice (n ¼ 5) from Day 1 (24-h post-hCG injection) to Day 5 were collected. Ovariectomized mice (n ¼ 4-5 per group) were injected with 100 ng/mouse estradiol (E 2 ), 1 mg/mouse progesterone (P 4 ), E 2 plus 3 mg/kg ICI 182780 (Tocris, Bristol, UK), or P 4 plus 1 mg/mouse RU 486 (Tocris Bioscience, Ellisville, MI) at 24 h before tissue collection.
Northern Blotting and Polymerase Chain Reaction
Total RNA from mouse tissues were isolated by the Absolutely RNA RT-PCR kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. The quality and quantity of the total RNA was checked by spectrophotometry and stored at À708C until use. Northern blotting was performed using cDNA probes obtained from the subtracted oviductal clone [5] . Normalized mouse cDNA panels (Clontech Laboratories, Mountain View, CA) were used to examine the expression of Ephx1 in mouse tissues. The PCR primers for Ephx1 and Gapdh were: Ephx1-forward, 5 0 -GAGAATTCCATGTGGCTGGAACTCATC-3 0 and Ephx1-reverse, 5 0 -GAGAATTCTGCAGCTCAGCCAGGGA-3 0 ; Gapdh-forward, 5
0 -ACCACAGTCCATGCCATCAC-3 0 and Gapdh-reverse, 5 0 -TCCAC CACCCTGTTGCTGTA-3 0 ; these produced amplicons of sizes 1382 bp (Ephx1) and 450 bp (Gapdh), respectively. The agarose gel also included 1-kb-plus DNA markers (Invitrogen, Carlsbad, CA). The PCR conditions were 26-38 cycles of 958C for 15 sec and 688C for 5 min. The amplified PCR products were separated on a 2% (w/v) agarose gel, stained with ethidium bromide, and visualized under ultraviolet (UV) illumination.
In Situ Hybridization
Paraffin embedded mouse oviducts were sectioned at 5 lm thick and were subjected to in situ hybridization using the mRNAlocator in situ hybridization kit (Ambion Inc., Austin, TX) as described previously [14, 15] . In brief, the dewaxed tissues were washed in PBS and treated with proteinase K for 10 min at room temperature. The tissues were washed sequentially with PBS for 5 min, 1.32% (v/v) triethanolamine for 3 min, 1.32% (v/v) triethanolamine with 0.25% (v/v) acetic anhydride for 10 min, and PBS for another 5 min at room temperature. The full length Ephx1 was cloned into the pGEM-T easy vector. DNA sequencing was performed using an automated 3730 DNA Analyzer (Applied BioSys, Foster City, CA) in the Genome Research Center, The University of Hong Kong. Antisense and sense riboprobes were generated with the T7/SP6 riboprobe combination system (Promega, Madison, WI) and 35 SdUTP nucleotide. The slides were allowed to hybridize overnight with hybridization buffer (from the mRNAlocator in situ hybridization kit) containing radioactive probe (1 3 10 6 cpm/slide) and stored in a humidified chamber at 558C. After hybridization, the slides were washed extensively to remove nonspecifically bound riboprobe. Tissue sections were washed successively with 4X standard saline citrate (4X SSC) buffer (1X SSC: 0.15 M NaCl and 15 mM sodium citrate) supplemented with 1 mM dithiothreitol (SCC/1mM DTT) for 5 min at 558C, followed by 2X SSC/1mM DTT for 30 min at 558C, and then treated with 20 lg/ml RNase A at 378C for 15 min. Slides were then washed in 2X SSC/1mM DTT for 30 min at 558C and then 0.1X SSC for another 30 min at 558C before dehydrating in ethanol and airdrying. RNase A resistant hybrids were detected after 1-2 wk of autoradiography using Kodak NTB-2 (GE Healthcare, Pittsburgh, PA) liquid emulsion. The slides were poststained with hematoxylin. Tissue sections were examined with a Zeiss Axioskop microscope (Photometrics Sensys, Roper Scientific, Tuesoa, AZ) under bright-and dark-field optics.
Quantitative Polymerase Chain Reaction
Total RNA templates from mouse tissues were transcribed into cDNA using the TaqMan Reverse Transcription Kit (Applied BioSystems). PCR was performed with the 2X TaqMan Universal PCR Master Mix and ABI 7500 realtime PCR machine (Applied BioSystems). Each sample was run in triplicate in two consecutive reactions with the amplification conditions set as follows: 508C for 2 min to optimize the AmpErase UNG enzyme activity, followed by 958C for 10 min to activate the AmpliTaq Gold DNA polymerase, and then 40 cycles of 958C for 15 sec and 608C for 1 min for the PCR. The resulting gene expression profile was determined using Rn18s (also known as 18S) as an endogenous standard. The PCR cycle number that generated the first fluorescence signals above a threshold value (threshold cycle [C T ]) was determined. This threshold was calculated as a value 10 times the standard deviations above the mean fluorescence generated during the baseline cycles. For the detection of the relative gene expression level, a comparative C T method (2 ÀDDCT method) was used.
Immunohistochemistry
Immunohistochemistry was performed as described [13] . Primary anti-EPHX1 antibody (Santa Cruz Biotech, Santa Cruz, CA) diluted at 1:20 in 10% (v/v) goat serum (Sigma, St. Louis, MO) was incubated with tissue sections at 48C overnight. After thorough washing with phosphate-buffered saline (PBS) containing 0.05% (v/v) Tween 20, the tissue sections were incubated with biotinylated polyclonal goat-anti rabbit IgG (DakoCytomation, Carpinteria, CA) at 1:300 dilution in 10% goat serum (Sigma), followed by StrepABComplex/HRP. A positive brown signal was visualized with 3,3 0 -diaminobenzidine as the substrate (DakoCytomation).
Intracellular and Extracellular Reactive Oxygen Species Measurement
The intracellular and extracellular reactive oxygen species (iROS and eROS, respectively) levels were measured using different probes purchased from Invitrogen. To determine the iROS level, oviductal cells (1 3 10 4 cells/ well) with or without the prior addition of 500 lM cyclohexene oxide (CHO) or 625 lM 1,1,1-trichloropropene-2,3-oxide (TCPO) treatment (see below) were incubated with 100 mM 5-(and 6-)chloromethyl-2,7-dichlorodihydrofluorescein diacetate acetyl ester (Invitrogen) for 15 min at 378C. One hundred microliter of the dissolved probe was diluted in 400 ll dimethyl sulfoxide immediately before use. After two subsequent washings with 100 ll Hanks buffered salt solution (HBSS), 100 ll of fresh HBSS was added to the cells, and 4 ll of the diluted probe was added directly to the culture medium. The cells were then incubated for 15 min in the dark at 378C before the fluorescence was measured at 388 nm/530 nm (excitation/emission) using a fluorescent plate reader (Infinite F200, Tecan Group Ltd., Switzerland).
The eROS level was detected using 10 lg/ml OxyBurst H 2 HFF-BSA (bovine serum albumin coupled to dihydro-2 0 ,4,5,6,7,7 0 -hexafluorofluorescein; Invitrogen). The 500 lM CHO-treated and untreated cells (1310 4 cells/well) in a 96-well plate were incubated with the dye for 2 min at 378C. The probe was immediately prepared by dissolving 10 ll of the dye in 1 ml of PBS. To every well, 100 ll of the diluted probe was added directly to the medium. After incubating for 2 min at 378C in the dark, the fluorescence reading was measured at 485 nm/530 nm (excitation/emission). The results were obtained from five repetitive reactions set in triplicate.
Mouse Embryos and OE-E6/E7 Cell Coculture
Human oviductal cells, OE-E6/E7, were immortalized in our laboratory under approved protocols as previously described [16] and were cultured in fresh 10% fetal bovine serum-supplemented Dulbecco modified Eagle medium: nutrient mixture F-12 until they were 70%-80% confluent. Mature ICR (CD-1) female mice (6-to 8-wk old) were superovulated with 5 IU equine chorionic gonadotropin (eCG; Sigma) and 5 IU human chorionic gonadotropin (hCG; Sigma) at 46 h post-eCG injection. The mice were mated with fertile BALB/c males (purchased from Charles River Laboratories, Wilmington, MA), and Day 1 was defined as the day when the vaginal plug was observed. The zygotes were retrieved from the oviductal ampullae at 24 h post-hCG injection after dispersion EPHX1 ON EMBRYO DEVELOPMENT 127 of the cumulus cells in M2 medium (Chemicon, Billerica, MA) containing 0.8 mg/ml hyaluronidase (Sigma). The zygotes were washed three times in 20 ll of M2 before being pooled into a droplet containing 80 ll of KSOMaa (amino acid supplemented KSOM medium; Millipore, Billerica, MA). Thirty to forty zygotes were randomly allocated and cocultured with OE-E6/E7 cells with or without 500 lM CHO or 625 lM TCPO. Zygotes cultured in medium alone with or without 500 lM of CHO or 625 lM TCPO were used as controls. The embryos were cultured for 48 h [12] and then transferred to another well containing fresh culture medium. The percentage of embryos reaching 2 cell, 3-4 cell, blastocyst, and hatching blastocyst stages were recorded at 24, 48, 96, and 120 h post-hCG, respectively. The image of each expanded blastocyst was captured by a phasecontrast-inverted microscope (Nikon Eclipse TE300). The diameter of the blastocysts was determined by MetaMorph Imaging System 9 version 3.51 (Universal Imaging Corp., West Chester, PA). The blastocyst sizes and blastulation and hatching rates obtained from three to five coculture experiments were pooled for analysis.
Statistical Analysis
All results were expressed as means 6 SEM. One-way analysis of variance (ANOVA) and Turkey test were subsequently performed using SigmaStat 2.03 (Jandel Scientific, San Rafael, CA). Chi-square test was used to compare embryo development after treatment. A probability of , 0.05 was considered as significantly different.
RESULTS
Suppression Subtractive Hybridization and Northern Blotting
Previously, we reported the detection of 97 out of 250 reamplified clones [14] that were differentially expressed in embryos [5, 14] . One clone, i.e., OD1, of size 450 bp and highly homologous to mouse Ephx1 (NM_010145), was further characterized in this study. Northern blot analysis of Ephx1 detected a transcript size of about 1.4-kb that was highly expressed in the mouse oviduct (Fig. 1A) . SignalP 3.0 analysis (http://www.cbs.dtu.dk/services/SignalP/) identified a signal peptide with a potential cleavage site at position 22. Using mouse cDNA panels, we confirmed a high expression level of Ephx1 transcript in the oviduct, followed by the lung, liver, and testis. The expression levels of Gapdh were similar for all the cDNA samples studied (Fig. 1B) .
In Situ Hybridization and Immunohistochemistry
Ephx1 mRNA was strongly localized to the luminal epithelium of the oviduct and weakly localized to the stromal layers. Very weak or no hybridization signal was detected when the sense probes were used. In line with this observation, EPHX1 protein was found to be highly expressed in the oviductal luminal epithelium (Fig. 2) . A much stronger signal was found in the isthmus than in the ampulla region of the mouse oviduct. Interestingly, EPHX1 immunoreactivity was also present in other reproductive tissues including testis, ovary, uterus, and epididymis (Cheong and Lee, unpublished results).
Quantitative PCR of Ephx1 Transcript in Mouse Oviduct
Quantitative PCR (qPCR) analysis on mouse oviduct at different stages of the estrus cycle showed that Ephx1 was highly expressed (P , 0.05) at the estrus stage when compared with the proestrus and the metestrus stages (Fig. 3A) . To confirm our previous observation that the preimplantation embryos might stimulate the expression of Ephx1 transcript in mouse oviduct, we isolated the total RNA from pregnant and pseudopregnant mouse oviduct from Day 1 to Day 5 of pregnancy. The qPCR analysis revealed that the relative Ephx1 transcript level increases from Day 1 to Day 3 and then decreased until Day 5 in pregnant mouse oviduct. The relative Ephx1 level in the   FIG. 1. A) Northern blot analysis of Ephx1 in mouse tissues. The membranes were hybridized with radioactive-labeled probe prepared from subtracted oviductal clones. The sizes of the transcripts are indicated on the left. The RNA gel stained with ethidium bromide was used as the loading control for the representative membranes. B, brain; K, kidney; L, liver; Lg, lung; Sp, spleen; H, heart; T, testis; Ov, ovary; Od, oviduct; and Ut, uterus. B) Semiquantitative analysis of Ephx1 transcript expression in mouse tissues. The amplified PCR products from the mouse ovary, oviduct, and multiple tissue cDNA panels (MTC I and II) were resolved in 2% agarose gel. The gel was stained with ethidium bromide and visualized under UV illumination. B, brain; Bm, bone marrow; E, eye; H, heart; K, kidney; L, liver; Lg, lung; Ln, lymph node; O, ovary; Od, oviduct; P, prostate; Sk, skeletal muscle; S, smooth muscle; Sp, spleen; St, stomach; T, testis; Th, thymus; U, uterus; 7, 7-day embryo; 11, 11-day embryo; 15, 15-day embryo; 17, 17-day embryo, þ, mouse MTC II positive control; -, negative control; and M, 1-kbplus DNA markers. A housekeeping gene, Gapdh, was used as the PCR loading control.
128 pseudopregnant mouse oviduct remains constant. Interestingly, there was a significant increase (P , 0.05) of Ephx1 transcript on Day 3 of pregnant mouse oviduct when compared with that of the pseudopregnant mouse (Fig. 3B) . Furthermore, immunohistochemistry performed on the pregnant and pseudopregnant mouse oviducts from Day 1 to Day 5 confirmed an increasing trend of Ephx1 expression from Day 1 to 3 before dropping off from Day 4, while the expression level remained fairly constant in the pseudopregnant mouse oviducts (data not shown).
To study if steroid hormones modulate Ephx1 expression in vivo, we used the ovariectomized mouse model to study the effect of estrogen-or progesterone-induced Ephx1 expression in the mouse uterus. Immunohistochemical staining suggested that E 2 and P 4 strongly induced the expression of Ephx1 in the luminal and glandular epithelial cells of the uterus (Fig. 3C) . The addition of steroid hormone-selective antagonists, i.e., E 2 plus ICI 182780 and P 4 plus RU 486, blocked the effects of the steroid hormones on Ephx1 expression.
The Effect of EPHX1 Inhibition on the ROS Levels in the OE-E6/E7 Culture
Fluorescent dyes were used to study the effect of EPHX1 inhibition by 500 lM of CHO and 625 lM of TCPO on the ROS level in the OE-E6/E7 culture. The CHO and TCPO concentrations used did not affect cell proliferation and viability (Supplemental Figure S1 available at www.biolreprod.org). Addition of CHO significantly increased (P , 0.05) the iROS levels of the OE-E6/E7 cells at 24, 48, and 72 h post-CHO treatment when compared to the untreated control (Fig. 4A) . A similar result was also obtained upon TCPO treatment (data not shown).
We studied the effect of CHO and TCPO on the eROS production in OE-E6/E7 cell culture by adding OxyBurst H 2 HFF-BSA fluorescence dye into the culture medium containing the cells. OE-E6/E7 cells treated with CHO had significantly higher eROS (P , 0.05) levels at 24, 48, and 72 h post-CHO treatment (Fig. 4B ) when compared to the untreated control. TCPO treatment produced similar results (data not shown). Although the eROS levels increased with time in the untreated group, the increase of eROS levels in the CHO-or TCPO-treated cells were significantly greater than that of the untreated cells. CHO and TCPO treatments did not affect the mRNA expression of embryotrophic factors, including those of the 120kDa oviduct-specific glycoprotein 1 (OVGP1) and complement component 3 (C3), suggesting that the drug treatments did not compromise the embryotrophic activity of the OE-E6/E7 cells (Supplemental Figure S1 ).
Embryos Cocultured with CHO-Treated OE-E6/E7 Cells
To determine the role of EPHX1 in human oviductal cells on embryo development, OE-E6/E7 cells were treated with CHO or TCPO prior to the coculture experiments. Embryos cocultured with OE-E6/E7 cells showed a significantly larger blastocyst size (17 644 6 445 vs. 13 758 6 300 pixel, P , 0.05) and higher blastulation rate (74.3% vs. 49.1%, P , 0.05) when compared to the KSOMaa medium alone (Table 1) . EPHX1 inhibitors, CHO (500 lM) or TCPO (625 lM), alone did not affect the blastocyst size (13 349 6 257 and 13 429 6 188 pixel, respectively) and the blastulation rate (51.7% and   FIG. 2 . Localization of Ephx1 in mouse oviduct. In situ hybridization (ISH) of Ephx1 transcript was carried out and Ephx1 mRNA was mainly localized to the luminal epithelium of the oviduct. Radioactive antisense (A and B) and sense (C and D) riboprobes were used to hybridize oviduct and visualized under bright (A and C) and dark (B and D) field images. Immunohistochemistry (IHC) of EPHX1 was carried out in mouse oviduct (E and F). Brown staining was mainly localized in the epithelial layer of mouse oviduct at the isthmus (E) but not in the ampulla (F) region. Bar ¼ 200 lm.
EPHX1 ON EMBRYO DEVELOPMENT 129 49.2%, respectively). However, CHO and TCPO neutralized the embryotrophic effect of OE-E6/E7 on preimplantation embryo development as demonstrated by reduction in the blastocyst sizes (10 940 6 319 and 12 335 6 334 pixel, respectively) and blastulation rates (39.2% and 38.9%, respectively), with the result that the CHO-and TCPO-treated embryos were similar to the control embryos.
DISCUSSION
Somatic cell coculture enhances embryo development, partially via the production of embryotrophic factor(s) and/or detoxification of harmful substances [3, 17] . Here, we demonstrated that oviductal EPHX1 may help to reduce ROS levels in the culture environment, thereby enhancing embryo development. A recent clinical study suggested that an increase in ammonium concentration in the culture medium reduces the development of human embryos to the blastocyst stage [18] . Moreover, reactive oxygen species also affect embryo development [8] via attacking biomolecules inside the cells.
Microsomal EH transcript is highly expressed in several tissues, including the reproductive tissues (Fig. 1) . Epoxide hydrolase in the liver plays a central role in the metabolic transformation of many aliphatic epoxides and arene oxides derived from drugs and environmental chemicals to yield the corresponding 1,2-diols, or glycols [9] . Maternal EH reduces 7,12-dimethylbenz[a]anthracene-induced developmental toxicity in mice [19] . EPHX1 is expressed in the granulosa and theca interna cells of human follicles. It is involved in ovarian estrogen production, as shown by the fact that an EPHX1 competitive inhibitor, 1,2-epoxy-3,3,3-trichloropropane, inhibited the conversion of testosterone to estradiol in the granulosa cells in vitro [20] . In mice, the nuclear factor, erythroid derived 2, like 2 (Nfe2l2, previously known as Nrf 2) blocks the basal and inducible expression of microsomal epoxide hydrolase. Nfe2l2À/À female mice (after 30 wk of age) were sensitive to 4-vinylcyclohexene diepoxide (VCD)-induced infertility. It was found that VCD selectively destroyed small ovarian follicles, resulting in early depletion of functional follicles [21] .
FIG. 3. Expression of Ephx1 in mouse oviduct and uterus.
A) The relative expression of Ephx1 transcript in mouse oviduct in estrus cycle was determined by qPCR. The C T values were normalized with eukaryotic Rn18s (also known as 18S) expression levels, and the expression of Ephx1 in proestrus, estrus, metestrus, and diestrus stages were calculated. B) qPCR analysis of Ephx1 transcript expression in the oviduct of pregnant (filled bar) and pseudopregnant (opened bar) mice. The relative expression of Ephx1 in day 3 pregnant mouse oviduct is significantly higher than that in the pseudopregnant (Pseudo-P) mouse oviduct. No immunostaining was found when the primary antibody was omitted (Negative). This change is not observed in other days of pregnancy. The labels a-b indicate significant differences (P , 0.05) between the groups on the same day. C) Immunohistochemical staining on the ovariectomized mouse uteri. The expression of Ephx1 in the ovariectomized mouse uterus (OVX), with exogenous estrogen only (OVXþE), with estrogen and antagonist ICI 182780 (OVXþEþICI), with exogenous estrogen and progesterone (OVXþEþP), with exogenous progesterone only (OVXþP), and with progesterone and antagonist RU 486 (OVXþPþRU) were studied. The positive brown staining was localized to the luminal epithelium. Bar ¼ 200 lm.
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Like many other oviductal proteins, the expression of Ephx1 is regulated by steroids in the reproductive tract. The pregnant mouse model demonstrated that preimplantation embryos stimulate Ephx1 transcript expression in the oviduct on Day 3 of pregnancy. Moreover, we demonstrated in the ovariectomized model that Ephx1 protein levels increased with administration of exogenous estrogen and progesterone. These steroid actions were confirmed by the ability of the estrogen antagonist ICI 182780 and the progesterone antagonist RU 486 to nullify the steroid-induced uterine expression of Ephx1. Interestingly, a putative estrogen response element, AAGGTTATTCTGCCCCT, was identified at 886 bp upstream of the Ephx1 translation start site, suggesting that estrogen may directly regulate Ephx1 expression in vivo.
Bioinformatic analysis identified a putative signal peptide suggestive of a secretory role of EPHX1 in the oviduct. However, we could not detect EPHX1 protein in the embryooviductal cell conditioned medium. EPHX1 has a strong hydrophobic transmembrane domain [9, 10] . Apart from its presence in the endoplasmic reticulum, it is likely that, as in the liver cells, EPHX1 is also present in the plasma membrane of oviductal and uterine epithelial cells. Indeed, the catalytic Cterminal domain of EPHX1 in liver cells faces extracellularly [9] . This is supported by the presence of a greater intensity of EPHX1 immunoreactivity at the apical border of these reproductive tract cells (Supplemental Figure S2 ). EPHX1 protein was mainly found in the luminal epithelium of the oviduct and the uterus, though a weaker signal was found in the stromal region of the endometrium (Fig. 3) . Transforming growth factor-b stimulates human myometrial smooth muscle cells to produce EPHX1 transcript in vivo [22] . We reported that Ephx1 was highly expressed in the oviduct-containing preimplantation embryos but not oocytes [14] , suggesting that the up-regulation of Ephx1 expression may be important in preimplantation embryo development. Yet, Ephx1-null (microsomal EH) mice were fertile and had no phenotypic abnormalities [23] .
In the lung, pulmonary EPHX1 eliminates ROS to protect pulmonary damage via oxidative stress [24, 25] . We hypothesized that the oviductal EPHX1 may have similar ROSscavenging activities. Here, we demonstrated that EPHX1 reduced ROS in the spent medium from oviductal cell culture. Addition of an EPHX1 inhibitor, CHO or TCPO, increased the eROS and iROS levels in oviductal cell culture (Fig. 4) , and neither inhibitor affected the cell proliferation and the expression of complement component 3 (C3) and 120kDa oviduct-specific glycoprotein 1 (OVGP1) transcripts in the oviductal cells. A high ROS level in the embryo culture medium is known to affect preimplantation embryo development by destroying nucleic acid stability, membrane rigidity, and normal enzyme activity [26] . Preimplantation embryos have a high oxidative phosphorylation rate via the cytochrome P450 monooxygenase system, thereby generating high levels of ROS in the cells [8] . ROS are highly diffusible across cell membranes, potentially leading to several possible kinds of damage such as the mitochondrial alternation, higher chances of cell cycle arrest, ATP depletion, and programmed cell death [8] . Embryos cocultured with CHO-or TCPO-treated OE-E6/ E7 cells had smaller blastocysts and lower blastulation rate when compared with the OE-E6/E7 coculture group. However, embryos cultured in medium alone or CHO-or TCPOsupplemented medium showed no change in developmental potentials. This suggested a beneficial effect of EPHX1 expressed in oviductal epithelial cells on embryo development in vitro.
Previously, we reported the purification of embryotrophic factor-3 (ETF-3) from human oviductal epithelial cells [27] . ETF-3 enhances embryo development in vitro [12, 13, 28] . It was subsequently identified as complement component 3 (C3) and its derivates [13] . The mouse embryos can covert the A) The changes in the intracellular ROS (iROS) levels in the OE-E6/E7 cultured for 72 h. The iROS levels in the OE-E6/E7 culture were detected using 100 mM 5-(and 6-)chloromethyl-2,7-dichlorodihydrofluorescein diacetate acetyl ester. When OE-E6/E7 cells were incubated with CHO (filled bar), the iROS levels were higher than the untreated group (open bar) from 24 h onward. B) The changes in the extracellular ROS (eROS) levels in the OE-E6/E7 cultured for 72 h. The iROS levels in the OE-E6/E7 culture were detected using 10 lg/ml OxyBurst H 2 HFF-BSA. When the cells were incubated with CHO (filled bar), the eROS levels were significantly higher than the untreated group (open bar) from 24 h onward. An asterisk (*) denotes a statistical significance between the compared groups (P , 0.05), whereas NS indicated an insignificant difference between the compared groups. EPHX1 ON EMBRYO DEVELOPMENT derivative of C3, C3b, into embryotrophic iC3b by CR1L (previously known as CRRY) present on the embryos [29] . Today, more than a dozen oviductal factors have been suggested to be related to embryo development [4] . Some of the identified oviductal factors, including granulocyte-macrophage colony-stimulating factor [30] , leptin [31] , complement protein component 3 [13] , and demilune cell and parotid protein 1 [15] , possess embryotrophic activity in vitro. Other factors such as serine (or cysteine) peptidase inhibitors (previously known as plasminogen activator inhibitor [PAI]-1) have been partially purified from porcine oviductal tissue during the estrous cycle and early pregnancy [32] .
In conclusion, the oviduct provides an optimal microenvironment for development of embryo partly by the production of growth factors and/or proteins. The identification of oviductal mRNA coding for Ephx1 differentially expressed in the presence of developing embryos, and its putative roles in the detoxification process, suggest that EPHX1 may play an important role on preimplantation embryo development, partly via the removal of harmful substances (e.g., ROS) during embryo development in vivo and in vitro. Detailed expression and functional characterization of the gene would further elucidate the mechanism of coculture cells in human in vitro fertilization settings.
